Annual Long Term Debt
$2.90 M
-$660.00 K-18.57%
December 31, 2023
Summary
- As of February 12, 2025, MTNB annual long term debt is $2.90 million, with the most recent change of -$660.00 thousand (-18.57%) on December 31, 2023.
- During the last 3 years, MTNB annual long term debt has fallen by -$432.70 thousand (-13.00%).
- MTNB annual long term debt is now -30.12% below its all-time high of $4.14 million, reached on December 31, 2021.
Performance
MTNB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$2.33 M
-$196.00 K-7.75%
September 30, 2024
Summary
- As of February 12, 2025, MTNB quarterly long term debt is $2.33 million, with the most recent change of -$196.00 thousand (-7.75%) on September 30, 2024.
- Over the past year, MTNB quarterly long term debt has dropped by -$738.00 thousand (-24.03%).
- MTNB quarterly long term debt is now -45.62% below its all-time high of $4.29 million, reached on September 30, 2021.
Performance
MTNB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
MTNB Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.6% | -24.0% |
| 3 y3 years | -13.0% | -24.0% |
| 5 y5 years | +2588.0% | -24.0% |
MTNB Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.1% | at low | -43.7% | at low |
| 5 y | 5-year | -30.1% | at low | -45.6% | at low |
| alltime | all time | -30.1% | -100.0% | -45.6% | -100.0% |
Matinas BioPharma Holdings Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.33 M(-7.8%) |
| Jun 2024 | - | $2.53 M(-6.8%) |
| Mar 2024 | - | $2.71 M(-6.3%) |
| Dec 2023 | $2.90 M(-18.6%) | $2.90 M(-5.7%) |
| Sep 2023 | - | $3.07 M(-5.2%) |
| Jun 2023 | - | $3.24 M(-4.7%) |
| Mar 2023 | - | $3.40 M(-4.4%) |
| Dec 2022 | $3.56 M(-14.2%) | $3.56 M(-3.5%) |
| Sep 2022 | - | $3.68 M(-4.2%) |
| Jun 2022 | - | $3.84 M(-3.8%) |
| Mar 2022 | - | $3.99 M(-3.6%) |
| Dec 2021 | $4.14 M(+24.5%) | $4.14 M(-3.4%) |
| Sep 2021 | - | $4.29 M(+36.9%) |
| Jun 2021 | - | $3.13 M(-3.0%) |
| Mar 2021 | - | $3.23 M(-2.9%) |
| Dec 2020 | $3.33 M(-11.3%) | $3.33 M(-2.7%) |
| Sep 2020 | - | $3.42 M(-2.6%) |
| Jun 2020 | - | $3.51 M(-3.1%) |
| Mar 2020 | - | $3.63 M(-3.3%) |
| Dec 2019 | $3.75 M | $3.75 M(-3.1%) |
| Sep 2019 | - | $3.87 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $3.99 M(-2.9%) |
| Mar 2019 | - | $4.11 M(+3715.5%) |
| Dec 2018 | $107.70 K(+59.1%) | $107.70 K(-12.2%) |
| Sep 2018 | - | $122.60 K(+19.0%) |
| Jun 2018 | - | $103.00 K(-11.2%) |
| Mar 2018 | - | $116.00 K(+71.3%) |
| Dec 2017 | $67.70 K(+312.8%) | $67.70 K(+41.3%) |
| Sep 2017 | - | $47.90 K(-6.8%) |
| Jun 2017 | - | $51.40 K(+272.5%) |
| Mar 2017 | - | $13.80 K(-15.9%) |
| Dec 2016 | $16.40 K(>+9900.0%) | $16.40 K(-13.7%) |
| Sep 2016 | - | $19.00 K(-8.2%) |
| Jun 2016 | - | $20.70 K(>+9900.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $15.30 K(>+9900.0%) | $15.30 K(-32.0%) |
| Sep 2014 | - | $22.50 K(-33.0%) |
| Jun 2014 | - | $33.60 K(-22.9%) |
| Mar 2014 | - | $43.60 K(>+9900.0%) |
| Dec 2013 | $0.00 | $0.00 |
FAQ
- What is Matinas BioPharma Holdings annual long term debt?
- What is the all time high annual long term debt for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual long term debt year-on-year change?
- What is Matinas BioPharma Holdings quarterly long term debt?
- What is the all time high quarterly long term debt for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly long term debt year-on-year change?
What is Matinas BioPharma Holdings annual long term debt?
The current annual long term debt of MTNB is $2.90 M
What is the all time high annual long term debt for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual long term debt is $4.14 M
What is Matinas BioPharma Holdings annual long term debt year-on-year change?
Over the past year, MTNB annual long term debt has changed by -$660.00 K (-18.57%)
What is Matinas BioPharma Holdings quarterly long term debt?
The current quarterly long term debt of MTNB is $2.33 M
What is the all time high quarterly long term debt for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly long term debt is $4.29 M
What is Matinas BioPharma Holdings quarterly long term debt year-on-year change?
Over the past year, MTNB quarterly long term debt has changed by -$738.00 K (-24.03%)